A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Clinical trial NCT03165721 · TERMINATED

Trial details

NCT number

NCT03165721

Sponsor

National Cancer Institute (NCI)

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-08-16

Primary completion

2020-02-24

Enrollment

9

View on ClinicalTrials.gov